
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epigenetics-based therapeutics for myocardial fibrosis
Xuping Li, Ying Yang, Sixuan Chen, et al.
Life Sciences (2021) Vol. 271, pp. 119186-119186
Closed Access | Times Cited: 41
Xuping Li, Ying Yang, Sixuan Chen, et al.
Life Sciences (2021) Vol. 271, pp. 119186-119186
Closed Access | Times Cited: 41
Showing 1-25 of 41 citing articles:
Histone acetyltransferase Kat2a regulates ferroptosis via enhancing Tfrc and Hmox1 expression in diabetic cardiomyopathy
Juan Zhen, Xia Sheng, Tianlong Chen, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 11
Juan Zhen, Xia Sheng, Tianlong Chen, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 11
YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoy
Hongfei Xu, Zhen Wang, Miao Chen, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 55
Hongfei Xu, Zhen Wang, Miao Chen, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 55
Novel Therapies for the Treatment of Cardiac Fibrosis Following Myocardial Infarction
Kamila Raziyeva, Yevgeniy Kim, Zharylkasyn Zharkinbekov, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2178-2178
Open Access | Times Cited: 34
Kamila Raziyeva, Yevgeniy Kim, Zharylkasyn Zharkinbekov, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2178-2178
Open Access | Times Cited: 34
Studies on the fat mass and obesity-associated (FTO) gene and its impact on obesity-associated diseases
Chaoqun Huang, Wei Chen, Xinxia Wang
Genes & Diseases (2022) Vol. 10, Iss. 6, pp. 2351-2365
Open Access | Times Cited: 32
Chaoqun Huang, Wei Chen, Xinxia Wang
Genes & Diseases (2022) Vol. 10, Iss. 6, pp. 2351-2365
Open Access | Times Cited: 32
ALKBH5 ameliorated liver fibrosis and suppressed HSCs activation via triggering PTCH1 activation in an m6A dependent manner
Jing‐Jing Yang, Juan Wang, Yang Yang, et al.
European Journal of Pharmacology (2022) Vol. 922, pp. 174900-174900
Open Access | Times Cited: 31
Jing‐Jing Yang, Juan Wang, Yang Yang, et al.
European Journal of Pharmacology (2022) Vol. 922, pp. 174900-174900
Open Access | Times Cited: 31
Roles of Epigenetics in Cardiac Fibroblast Activation and Fibrosis
Jingrong Shao, Jiao Liu, Shengkai Zuo
Cells (2022) Vol. 11, Iss. 15, pp. 2347-2347
Open Access | Times Cited: 20
Jingrong Shao, Jiao Liu, Shengkai Zuo
Cells (2022) Vol. 11, Iss. 15, pp. 2347-2347
Open Access | Times Cited: 20
N6-methyladenosine (m6A) RNA modification in fibrosis and collagen-related diseases
Man Tan, Siyi Liu, Lubin Liu
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Man Tan, Siyi Liu, Lubin Liu
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Regulatory mechanisms of m6A methylation in dilated cardiomyopathy
Hao Zhang, Haiyang Guo, Fengjiao Han, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 1, pp. 47-59
Closed Access
Hao Zhang, Haiyang Guo, Fengjiao Han, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 1, pp. 47-59
Closed Access
A comprehensive study on the impact of Ligustrum vicaryi L. fruit polysaccharide on myocardial fibrosis through animal experiments, network pharmacology and molecular docking
Shuling Liu, Meifang Liu, Jianan Wang, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Shuling Liu, Meifang Liu, Jianan Wang, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Salvia miltiorrhiza Bunge root in the treatment of myocardial fibrosis: research progress and challenges
Qianrong Li, Chunzhen Ren, Bing Jiang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Qianrong Li, Chunzhen Ren, Bing Jiang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Cardiac protection of wogonin in mice with pulmonary fibrosis by regulating Sirt1/ γ-H2AX pathway
Libo Wang, Fei Lin, Runran Miao, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Libo Wang, Fei Lin, Runran Miao, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Synthesis of amide derivatives containing the imidazole moiety and evaluation of their anti‐cardiac fibrosis activity
Yuxuan Yang, Jia Guo, Chuang Liu, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 8
Closed Access | Times Cited: 3
Yuxuan Yang, Jia Guo, Chuang Liu, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 8
Closed Access | Times Cited: 3
EPHB2 Knockdown Mitigated Myocardial Infarction by Inhibiting MAPK Signaling
Xiao‐Yan Jiang, Wenhua Wang, Haofei Kang
Advanced Biology (2024) Vol. 8, Iss. 9
Closed Access | Times Cited: 3
Xiao‐Yan Jiang, Wenhua Wang, Haofei Kang
Advanced Biology (2024) Vol. 8, Iss. 9
Closed Access | Times Cited: 3
Ferroptosis in diabetic cardiomyopathy: Advances in cardiac fibroblast-cardiomyocyte interactions
Mengmeng Wang, De-Gang Mo, Ning Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35219-e35219
Open Access | Times Cited: 3
Mengmeng Wang, De-Gang Mo, Ning Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35219-e35219
Open Access | Times Cited: 3
PiRNA CFAPIR inhibits cardiac fibrosis by regulating the muscleblind-like protein MBNL2
Lin Lv, Keying Yuan, Jiahao Li, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 8, pp. 167456-167456
Closed Access | Times Cited: 3
Lin Lv, Keying Yuan, Jiahao Li, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 8, pp. 167456-167456
Closed Access | Times Cited: 3
Epigenetic Regulation in Myocardial Fibroblasts and Its Impact on Cardiovascular Diseases
Sumra Komal, Yuan Gao, Zhi-Mo Wang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1353-1353
Open Access | Times Cited: 3
Sumra Komal, Yuan Gao, Zhi-Mo Wang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1353-1353
Open Access | Times Cited: 3
Biomarcadores Potenciais na Fibrose Miocárdica: Uma Análise Bioinformática
Wang Cheng-Mei, Gang Luo, Ping Liu, et al.
Arquivos Brasileiros de Cardiologia (2024) Vol. 121, Iss. 12
Open Access | Times Cited: 3
Wang Cheng-Mei, Gang Luo, Ping Liu, et al.
Arquivos Brasileiros de Cardiologia (2024) Vol. 121, Iss. 12
Open Access | Times Cited: 3
N‐acetyltransferase 10 promotes the progression of oral squamous cell carcinoma through N4‐acetylcytidine RNA acetylation of MMP1 mRNA
Yi Liu, Hui Huang, Cun‐bao Zhang, et al.
Cancer Science (2023) Vol. 114, Iss. 11, pp. 4202-4215
Open Access | Times Cited: 8
Yi Liu, Hui Huang, Cun‐bao Zhang, et al.
Cancer Science (2023) Vol. 114, Iss. 11, pp. 4202-4215
Open Access | Times Cited: 8
Epigenetic alterations of TGFβ and its main canonical signaling mediators in the context of cardiac fibrosis
Luis Algeciras, Ana Palanca, David Maestro, et al.
Journal of Molecular and Cellular Cardiology (2021) Vol. 159, pp. 38-47
Closed Access | Times Cited: 18
Luis Algeciras, Ana Palanca, David Maestro, et al.
Journal of Molecular and Cellular Cardiology (2021) Vol. 159, pp. 38-47
Closed Access | Times Cited: 18
Emerging role of m6A modification in fibrotic diseases and its potential therapeutic effect
Wufei Ye, Xiongwen Lv, Songsen Gao, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115873-115873
Closed Access | Times Cited: 7
Wufei Ye, Xiongwen Lv, Songsen Gao, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115873-115873
Closed Access | Times Cited: 7
Butyric Acid Ameliorates Myocardial Fibrosis by Regulating M1/M2 Polarization of Macrophages and Promoting Recovery of Mitochondrial Function
Xiaogang Li, Ruixuan Li, Nana You, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 12
Xiaogang Li, Ruixuan Li, Nana You, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 12
NAT10‐mediated RNA ac4C acetylation contributes to the myocardial infarction‐induced cardiac fibrosis
Jun Li, Feierkaiti Yushanjiang, Zhao Fang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 21
Open Access | Times Cited: 2
Jun Li, Feierkaiti Yushanjiang, Zhao Fang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 21
Open Access | Times Cited: 2
Uncovering the molecular mechanisms of Curcumae Rhizoma against myocardial fibrosis using network pharmacology and experimental validation
Meng Zhang, Pengyu Lu, Fusen Zhao, et al.
Journal of Ethnopharmacology (2022) Vol. 300, pp. 115751-115751
Open Access | Times Cited: 10
Meng Zhang, Pengyu Lu, Fusen Zhao, et al.
Journal of Ethnopharmacology (2022) Vol. 300, pp. 115751-115751
Open Access | Times Cited: 10
N6-methyladenosine (m6A) RNA modification in the pathophysiology of heart failure: a narrative review
Sihan Liu, Tongyu Wang, Zeyi Cheng, et al.
Cardiovascular Diagnosis and Therapy (2022) Vol. 12, Iss. 6, pp. 908-925
Open Access | Times Cited: 10
Sihan Liu, Tongyu Wang, Zeyi Cheng, et al.
Cardiovascular Diagnosis and Therapy (2022) Vol. 12, Iss. 6, pp. 908-925
Open Access | Times Cited: 10
SMOC2 plays a role in heart failure via regulating TGF-β1/Smad3 pathway-mediated autophagy
Yu Ren, Yun Wu, Wenshuai He, et al.
Open Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 6
Yu Ren, Yun Wu, Wenshuai He, et al.
Open Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 6